Investors in Chemical

We’re (not just) investors. We’re (more than) advisors. We’re (beyond) connectors. Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seed stage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.

Refactor Capital is a seed-stage venture capital firm investing in founders solving fundamental human problems in areas such as bio and health. Zal Bilimoria is the Founding Partner of Refactor, along with David Lee of SV Angel.

Arsenal Capital Partners is a private equity firm that offers investment services to middle-market industrial and healthcare companies. It was founded in 2000 and is based in New York.

The Slater Technology Fund is an independently chartered economic development fund that operates in accord with best practices of venture capital investing, backing new ventures committed to basing and building businesses in Rhode Island. Leveraging state and federal funding, Slater focuses its resources on the support of entrepreneurs who have the vision, leadership and commitment to build substantial commercial enterprises. Slater typically invests at the inception stage in the development of a new venture, often based upon ideas and technologies originating in academic institutions and/or government research laboratories located within the region. In most cases, investments are premised upon the possibility of raising substantial follow-on financing, from venture capital investors or from strategic partners, with a view toward accelerating the generation of significant numbers of high-value, high-wage jobs over the intermediate to longer-term.

Founded in 1982, The Jordan Company is a middle-market private equity firm that invests in businesses across a wide range of industries. The firm is focused on leverage buyouts and recapitalizations.

Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrödinger, Inc.; an agreement with Daiichi Sankyo; collaboration with Northeastern University; and partnership with Boys & Girls Clubs of America. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.

Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated chemicals with 2013 revenues of over $11 billion. Their chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. They operate more than 80 manufacturing and R&D facilities in 30 countries and employ approximately 12,000 associates within their 5 distinct business divisions.

Elm Street Ventures is a venture capital firm specializing in investments in seed, startups, and early stage. It seeks to invest in life sciences and technology companies founded on intellectual property developed at Yale University and other research institutions in the region (from New York City through Southern New England). In life sciences the firm focuses on therapeutics, medical devices, laboratory tools, diagnostics, research tools and services, materials, healthcare, and healthcare services and in technology companies it invests in software, green technology, clean technology, green chemistry, information technology, mobile, and social web. The firm prefers to invest in or near New Haven, however this is not a requirement. It typically makes initial investments from several hundred thousand dollars to $1 million or more, with follow-on investments. The firm may invest in a syndicate with other institutional investors. Elm Street Ventures is based in New Haven, Connecticut.

Foresight Group is an alternative asset manager with a strong 30-year track record and specific expertise in environmental and solar infrastructure and private equity. Foresight Group is a leading independent infrastructure and private equity investment manager which has been managing investment funds on behalf of institutions and retail clients for 30 years. With current assets under management of over £2.2 billion, raised from the UK and international private and high-net-worth individuals, family offices, pension funds and other institutional investors, Foresight strives to generate increasing dividends and capital appreciation for its investors over the long term. Foresight has offices in UK, USA, Italy, and Australia.

Founded in 1992, Advantage Capital Partners is a venture capital firm specialised in equity and debt investments. The firm has worked with state and federal economic organisations to invest in small businesses and in low income areas.